DealsInflexion-backed Rosemont picks up Lucis PharmaLucis Pharma is a provider in the development and licensing of novel and exclusive medicines.ByNina Lindholm16 June 2023•1 min readJavaScript is required to read this article. Please enable it in your browser and reload the page.DealsEuropeUKWestern EuropeHealthcare